Stock Market Live Stream

BeyondSpring Inc (NASDAQ: BYSI) recently announced positive topline data from its DUBLIN-3 registrational trial in plinabulin in combination with docetaxel for the treatment of second and third line non-small cell lung cancer. The study showed survival benefits and side effect...